ARIAD PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Revenue:
Product revenue, net
License, collaboration and other revenue
Service revenue
Total revenue
Operating expenses:
Cost of product revenue
Research and development expense
Selling, general and administrative expense
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Interest expense
Gain on disposition of stock
Revaluation of warrant liability
Foreign exchange gain (loss)
Other expense, net

Loss before provision for income taxes
Benefit from (provision for) income taxes
Net loss
Net loss per share - basic and diluted
Weighted-average number of shares of common stock outstanding - basic and diluted

Comments